This study investigates the clinical and psychological implications of modern weight loss trends, focusing on the use of GLP-1 receptor agonists like Semaglutide and Tirzepatide. It highlights severe risks such as gastroparesis, renal impairment, and muscle atrophy, while addressing the societal pressures and the "thinness ideal" prevalent in the digital age. The paper advocates for sustainable health practices and psychological self-reconciliation over aggressive pharmacological interventions.
Sulaf Shammous (Fri,) studied this question.